Skip to main content
OpenTrials
Completed

NCT Number: NCT00630188

Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial

The purpose of this study is to determine whether an intervention designed to help men share decisions about prostate cancer screening with their physician results in better decision making, more shared decisions, and changes in intended and actual screening rates.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Chapel Hill North General Internal Medicine Practice, Chapel Hill, North Carolina, United States

Loading trial locations.

About this study

Background: Professional societies recommend shared decision making for prostate cancer screening, however, most effort has been directed at informed rather than shared decision making. In this study, we plan to test the effects of a shared decision making intervention on key components of shared decision making. We secondarily plan to test its effects on the presence of a shared decision, men's intention to be screened, and actual screening rates.

Methods: We plan to conduct two separate randomized controlled trials of shared decision making interventions, one in which the intervention focuses on prostate cancer screening only and one in which the intervention focuses on prostate cancer screening in the context of other men's health issues. Each trial will use the same attention control and identical implementation and measurement strategies to allow combination of data if no differences exist in the effect of the interventions. Trials will include a convenience sample of men with no prior history of prostate cancer who present to their primary care physician for routine care. Men will be randomly assigned to a shared decision making intervention (including a video and coaching session for patients and an education session for providers) or a control group, in which men will receive a video on highway safety. Data on key components of shared decision making and intent for screening will be measured at baseline, after the intervention, and after men's visit with their provider. Additionally, medical charts will be reviewed 9 months later to assess for actual screening.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 40-80 years
  • Their physician agreed to participate in the study
  • Seen in practice for at least one year

Exclusion criteria

  • Prior history of prostate cancer
  • Presenting for acute medical visit
  • Non-skin cancer
  • Lung disease requiring oxygen
  • Renal failure requiring dialysis
  • Intensive care visit in last 6 months
  • Need assistance with activities of daily living

Treatment and study plan

You Decide

Other

For Patients: Video-based decision aid on prostate cancer screening, One-on-One values clarification session with research assistant, One-on-One coaching session with research assistant to encourage good interaction with clinician

For Physicians: a one-time educational session on prostate cancer and the value of shared decision making

Reducing Your Risks in the Crash

Other

Publicly available video on highway safety and reducing individual risks in a crash

Primary outcomes

  1. Men's understanding that prostate cancer screening requires a decision

    Time frame: baseline, post intervention, post clinical visit

  2. Men's knowledge about prostate cancer and prostate cancer screening

    Time frame: baseline, post intervention, post clinical visit

  3. Men's participation in the decision about prostate cancer screening with their clinician at their preferred level

    Time frame: baseline, post intervention, post clinical visit

Secondary outcomes

  1. The presence of a shared decision

    Time frame: post clinical visit

  2. men's intent to be screened for prostate cancer

    Time frame: post clinical visit

  3. Self reported screening

    Time frame: post visit

  4. Actual screening by chart review

    Time frame: 9 month follow-up

Sponsors and collaborators

Lead sponsor

University of North Carolina

Other

Collaborators

  • RTI International

Registry information

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Mar 6, 2008
Registry last updated
Mar 6, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.